Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant additions or deletions observed; the page content, including study details and location listings, appears unchanged aside from minor formatting and UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T10:10:12.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an important government-operating-status notice; v3.1.0 is removed.
    Difference
    3%
    Check dated 2025-10-07T23:19:59.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Version bump: replacing v3.0.2 with v3.1.0 in the page metadata.
    Difference
    0.1%
    Check dated 2025-09-30T02:41:25.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Removed sections on MedlinePlus drug safety topics, counterfeit drugs, pharmaceutical preparations, and substandard drugs, narrowing the page’s coverage of drug safety and pharmacology.
    Difference
    0.4%
    Check dated 2025-09-22T23:37:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 (minor patch); removed the 'Back to Top' link, a small navigation change; core content remains unchanged.
    Difference
    0.2%
    Check dated 2025-09-15T19:21:41.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-08T15:00:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.